The expanded agreement solidifies Patheon as a preferred supplier to Merck. Patheon’s projects and services are expected to be delivered to Merck from eight of its global facilities.
Wes Wheeler, president and CEO of Patheon, said: “We have developed a great partnership with Merck and are very pleased that they have chosen to expand it with this contract manufacturing agreement. This expanded contract with Merck validates that we are making great progress towards meeting this goal.”